Al Fadhli et al. screened 122 patients with MS and 188 healthy individuals for SNVs of NOS1 (see Section 2.1.9 on “Multiple Sclerosis” regarding NOS1), NOS2 (CCTTT)n/(TAAA)n, and NOS3(see Section 2.4.10 on “Multiple Sclerosis” regarding NOS3). This evidence concerns the gene NOS2 and myeloid sarcoma.